Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y014307 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
patient did not report any adverse issues or side effect from the administered dose; temperature excursion on 01/02/2025 with a "short-dated" expiration date of 04/02/2025.; This spontaneous report was received from a medical assistant referring an approximately 5-year-old female patient. Her medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not reported. On 02-Jan-2025, Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) underwent a temperature excursion of 69 degrees Fahrenheit (F) for 4 hours, 20 minutes and 0 seconds with no additional excursions. On 04-Apr-2025, the patient inadvertently received an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), injection (batch/lot number Y014307 has been verified to be a valid batch/lot number for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, expiration date reported as "short-dated" expiration date of 04-Apr-2025 and 18-Feb-2026, but upon internal validation established as 18-Feb-2026) 0.5 mL (dosage regimen, anatomical location and route of administration were not reported) administered as prophylaxis (product storage error), which was diluted with sterile diluent (MERCK STERILE DILUENT), 0.5 mL (expiration date, and lot # were not reported.) The patient did not report any adverse issues or side effect from the administered dose (no adverse event.) This was one of two reports received from the same reporter.